Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Contact Lead Director

Governance Overview | Management Team | Board of Directors | Committee Composition | Contact Lead Director

Anyone wishing to communicate with CRL's non-management directors may contact the Lead Director (currently, George M. Milne, Jr.):

by mail, addressed to Lead Director c/o Corporate Secretary, 251 Ballardvale Street, Wilmington, MA 01887 or

by email at CRLLeadDirector@crl.com

All communications will be kept confidential and forwarded, as appropriate, by the CRL Corporate Secretary directly to the Lead Director.

Certain items which are unrelated to the duties and responsibilities of the Board will not be forwarded to the Lead Independent Director, such as spam, junk mail and mass mailings, customer complaints or inquiries, new product or service suggestions, resumes and other forms of job inquiries, surveys, and business solicitations or advertisements. In addition, materials that is unduly hostile, threatening, illegal or similarly unsuitable will not be forwarded.

Stock Quote

CRL (common)
Price
$118.81
Change (%)
+ 1.22 (1.04%)
Volume
265,012
Exchange
NYSE
Data as of 01/23/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)